Incyte | INCY - Umsatzerlöse





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agenus USD 33.7M 500K 2026-03
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Exelixis USD 658.69M 30M 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
MacroGenics USD 32.83M 12.03M 2026-06
Merck USD 18.1B 1.5B 2026-09
Moderna USD 1.31M 98.69M 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Novartis USD 15.03B 1.92B 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09